SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-04-027057
Filing Date
2004-09-08
Accepted
2004-09-08 13:48:39
Documents
4
Period of Report
2004-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a04-10328_18k.htm 8-K 32340
2 EX-10.159 a04-10328_1ex10d159.htm EX-10.159 20567
3 EX-10.160 a04-10328_1ex10d160.htm EX-10.160 43872
4 EX-10.161 a04-10328_1ex10d161.htm EX-10.161 42327
  Complete submission text file 0001104659-04-027057.txt   141207
Mailing Address 5931 DARWIN COURT CARLSBAD CA 92008
Business Address 5931 DARWIN COURT CARLSBAD CA 92008 7604317080
IMMUNE RESPONSE CORP (Filer) CIK: 0000817785 (see all company filings)

IRS No.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-18006 | Film No.: 041020291
SIC: 2836 Biological Products, (No Diagnostic Substances)